Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 4392

BillFederalHouseIn Committee
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
About This Bill
Committee
Latest Action · July 15, 2025
Referred to the House Committee on Energy and Commerce.
Congress
119th (2025–2027)
Introduced
July 15, 2025
Cosponsors (54)
54D 0R
View PDF ↗

Summary

Highlight any text to annotate
This bill directs the Department of Health and Human Services to conduct research on early detection and treatment of uterine fibroids and to develop evidence-based strategies for healthcare providers. The legislation authorizes the secretary to award grants to states for programs that increase early detection through screening and imaging, provide patient navigation services, and run public awareness campaigns about uterine fibroids. Grants will prioritize states serving socially vulnerable populations with higher risk of developing the condition. The bill also supports research into pain management disparities in fibroid surgery treatment and related gynecological conditions like Asherman's Syndrome. The secretary must report to Congress every two years on the results and findings from funded programs, though the legislation does not specify a total funding amount or authorization level.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.